Evidence map›Paper›PMID 39905765›Full record

ArticlePsychological medicine2025

Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors.

Laura Ferraro, Marta Di Forti, Daniele La Barbera, Caterina La Cascia, Craig Morgan, Giada Tripoli, Hannah Jongsma, Fabio Seminerio, Crocettarachele Sartorio, Lucia Sideli and 25 more

Abstract read
In one paragraph

Article in Psychological medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Laura FerraroDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.ORCID https://orcid.org/0000-0002-1205-2356
Marta Di FortiDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.
Daniele La BarberaDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.
Caterina La CasciaDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.
Craig MorganDepartment of Health Service and Population Research, Institute of Psychiatry, King's College London, London, UK.
Giada TripoliDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.
Hannah JongsmaCenter for Transcultural Psychiatry Veldzicht, Balkbrug, Overijssel, The Netherlands.
Fabio SeminerioDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.
Crocettarachele SartorioDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.
Lucia SideliDepartment of Human Science, LUMSA University, Rome, Italy.
Ilaria TarriconeDepartment of Medical and Surgical Science, Psychiatry Unit, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Anna Lisa CarloniDepartment of Medical and Surgical Science, Psychiatry Unit, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Andrei SzokeINSERM Créteil, France.
Baptiste PignonINSERM Créteil, France.
Miguel BernardoSchizophrenia Unit, Barcelona Clinic, Hospital Clínic de Barcelona.
Lieuwe de HaanDepartment of Psychiatry, Early Psychosis Section, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Celso ArangoIiSGM, CIBERSAM, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
Eva VelthorstDepartment of Research, GGZ Noord-Holland-Noord, Heerhugowaard, The Netherlands.
Charlotte Gayer-AndersonDepartment of Health Service and Population Research, Institute of Psychiatry, King's College London, London, UK.
James KirkbrideDivision of Psychiatry, University College London, Psylife Group, London, UK.
Bart P F RuttenDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
Antonio LasalviaDepartment of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
Sarah TosatoDepartment of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
Cristina Marta Del BenDepartment of Neuroscience and Behaviour, Universidade de Sao Paulo Campus de Ribeirao Preto, Division of Psychiatry, Sao Paulo, Brazil.
Paulo Rossi MenezesDepartamento de Medicina Preventiva FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Julio BobesPsychiatry, Universidad de Oviedo Facultad de Medicina, Sao Paulo, Brazil.
Manuel ArrojoComplexo Hospitalario Universitario de Santiago de Compostela, Department of Psychiatry, Psychiatric Genetic Group, Instituto de Investigacion Sanitaria, Sao Paulo, Brazil.
Andrea TortelliEtablissement Public de Sante, Maison Blanche Hospital, Sao Paulo, Brazil.
Peter JonesCambridgeshire and Peterborough NHS Foundation Trust, CAMEO Early Intervention Service, Cambridge, UK.
Jean-Paul SeltenMaastricht Universitair Medisch Centrum, School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Maastricht, Limburg, NL.
Jim van OsMaastricht Universitair Medisch Centrum, School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Maastricht, Limburg, NL.
WP2 EU-GEI Group
Robin MurrayDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.
Diego QuattroneDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.
Evangelos VassosSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London.

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2012/0417-0King's College LondonNational Institute for Health and Care ResearchNIHR Maudsley Biomedical Research Centre
6 · The paper itself

Abstract

backgroundPrevious studies identified clusters of first-episode psychosis (FEP) patients based on cognition and premorbid adjustment. This study examined a range of socio-environmental risk factors associated with clusters of FEP, aiming a) to compare clusters of FEP and community controls using the Maudsley Environmental Risk Score for psychosis (ERS), a weighted sum of the following risks: paternal age, childhood adversities, cannabis use, and ethnic minority membership; b) to explore the putative differences in specific environmental risk factors in distinguishing within patient clusters and from controls.

methodsA univariable general linear model (GLS) compared the ERS between 1,263 community controls and clusters derived from 802 FEP patients, namely, low (n = 223) and high-cognitive-functioning (n = 205), intermediate (n = 224) and deteriorating (n = 150), from the EU-GEI study. A multivariable GLS compared clusters and controls by different exposures included in the ERS.

resultsThe ERS was higher in all clusters compared to controls, mostly in the deteriorating (

conclusionsHigh exposure to environmental risk factors might result in cognitive impairment and lower-than-expected functioning in individuals at the onset of psychosis. Some patients' trajectories involved risk factors that could be modified by tailored interventions.

Indexed as

Adverse Childhood ExperiencesCognitive DysfunctionPsychotic DisordersAdolescentAdultCase-Control StudiesFemaleHumansMalePaternal AgeRisk FactorsYoung Adultcannabischildhood abusecluster analysisIQmigrationrisk factors

Identifiers

PMID39905765
PMCPMC11968123

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.